Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Orally active anticoagulants described by Daiichi

June 2, 1999

New perspectives for rFVIIa and rFVIIai

June 1, 1999

Fragmin approved in U.S. for treatment of unstable angina and non-Q wave MI

May 31, 1999

Avigen cleared to begin human trials of gene therapy product for hemophilia

May 26, 1999

Thrombin inhibitors developed by Merck scientists

May 13, 1999

Yamanouchi describes novel series of factor Xa inhibitors

May 10, 1999

Kissei develops new anticoagulants acting selectively against factor Xa

May 7, 1999

Glaxo Wellcome dicloses novel class of serine protease inhibitors

May 6, 1999

Antithrombotic agents synthesized and tested at Roche

May 5, 1999

Inhibitors of factor Xa recently disclosed by DuPont

May 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...